Structure of a novel sialylated fucosyl lacto-N-norhexaosylceramide isolated from chronic myelogenous leukemia cells.
A novel sialylated fucosyl glycolipid, which is present at an elevated level in chronic myelogenous leukemia cells, was isolated. The structure of this fucoganglioside was elucidated by methylation analysis, fast atom bombardment-mass spectrometry, and enzymatic degradation, followed by reaction with anti-Lex, Gal beta 1----4 (Fuc alpha 1----3) GlcNAc beta 1----, monoclonal antibody. The structure of this ganglioside was found to be: (Formula: see text). This structure is unique in that a fucose is attached to the internal N-acetylglucosamine but not to the subterminal N-acetylglucosamine. Since this glycolipid is apparently absent in normal granulocytes or acute myelogenous leukemia cells, it can be a specific marker for chronic myelogenous leukemia cells. Based on the structures of this fucoganglioside and normal granulocyte glycolipids, a biosynthetic pathway of extension, sialylation, followed by fucosylation is proposed.
Fukuda
M N
MN
Dell
A
A
Tiller
P R
PR
Varki
A
A
Klock
J C
JC
Fukuda
M
M
D000911:Antibodies, Monoclonal; D002851:Chromatography, High Pressure Liquid; D005732:Gangliosides / Q000302:isolation & purification*; D006098:Granulocytes / Q000032:analysis; D006801:Humans; D007122:Immunoelectrophoresis; D007951:Leukemia, Myeloid / Q000378:metabolism*; D013058:Mass Spectrometry; D011499:Protein Processing, Post-Translational
D000911:Antibodies, Monoclonal; D005732:Gangliosides; C047896:sialyl-fucosyl-lacto-N-norhexaosylceramide